Walleye Trading LLC Anavex Life Sciences Corp. Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.04 - $9.95 $103,183 - $203,706	20,473 New	20,473 $190,000
Q2 2022 Aug 08, 2022	BUY	$7.31 - $12.84 $209,650 - $368,251	28,680 New	28,680 $287,000
Q4 2021 Feb 14, 2022	SELL	$16.88 - $23.31 $2,396 - $3,310	-142 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$16.82 - $25.75 $1.03 Million - $1.57 Million	-60,999 Reduced 99.77%	142 $3,000
Q2 2021 Aug 16, 2021	BUY	$10.16 - $28.86 $621,192 - $1.76 Million	61,141 New	61,141 $1.4 Million

155

27.3M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $673M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.